Table 2.
Sr. No. | Activity | Model/Method | Dose/Duration | Component Used | Result | Reference |
---|---|---|---|---|---|---|
1 | Antioxidant/anti-aging | DPPH antioxidant assay | 6.25–200 (µg/mL) | P. erosus peel ethanolic extract | IC50 = 84.09 ± 4.87 (µg/mL) | [7] |
DPPH antioxidant assay | 6.25–200 (µm/mL) | P. erosus tuber ethanolic extract | IC50 = 98.30 ± 1.30 (µm/mL) | [7] | ||
Tyrosinase activity inhibition | 3.13–100 (µg/mL) | P. erosus peel ethonolic extract | IC50 = 194.51 ± 7.63 (µm/mL) | [7] | ||
Tyrosinase activity inhibition | 3.13–100 (µg/mL) | P. erosus tuber ethonolic extract | IC50 = 97.05 ± 0.86 (gm/mL) | [7] | ||
Scavenging activity on ABTS radical (IC50) | 100 µL at different concentrations | P. erosus water extract | IC50 = 1825.16 ± 22.87 (µg/mL) | [5] | ||
Scavenging activity on ABTS radical (IC50) | 100 µL at different concentrations | P. erosus (70%) ethanol extract | IC50 = 1711.71 ± 58.09 (µg/mL) | [5] | ||
DPPH antioxidant assay | 100 µL at different concentrations | P. erosus water extract | IC50 = 1215.65 ± 65.99 (µgm/mL) | [5] | ||
DPPH antioxidant assay | 100 µL at different concentrations | P. erosus (70%) ethanol extract | IC50 = 998.10 ± 117.71(µg/mL) | [5] | ||
2 | Anti-diabetes | α-glucosidase inhibitory assay | 0.05–0.25 (µg/mL) | P. erosus tuber extract | IC50 = 0.083 ± 0.004 (mg/mL) | [60] |
α-amylase inhibitory activity | 0.05–0.25 (µg/mL) | P. erosus tuber extract | IC50 = 0.091 ± 0.017 (mg/mL) | [60] | ||
3 | Immune modulation | ELISA is used to measure antibodies on HB4C5 cells and splenocytes | Sample conc. 0.1–100 (mg/mL) | P. erosus tuber fiber extract | The production levels of immunoglobulin, i.e., IgM, IgG, and IgA, as well as cytokines, were significantly enhanced | [86] |
Phagocytosis activity J774.1 cell/P-Mac cells | 1.69, 6.75, and 27 mg/mL | P. erosus tuber fiber extract | An increase in phagocytosis activity and the production of pro-inflammatory cytokines was observed | [84] | ||
4 | Antiviral | Plaque reduction assay was performed for HSV-1 (KOS) or HSV-2 |
100 µL at different concentrations | Compounds isolated from seeds | 12a-hydroxydolineone and 12a-hydroxypachyrrhizone found to have activity against both HSV-1 and -2 | [9] |
5 | Antifungal | Growth inhibitory effects on fungi | 0.5, 2.0, 5.0, and 10 mg/mL | P. erosus seed powder | −2 to −15% (inhibition) | [13] |
Growth inhibitory effects on fungi | 2.0, 5.0 and 10 mg/mL | P. erosus seed extract with hexane, dicloromethane, and acetone | 5.4 to −64.9% (inhibition) | [13] | ||
Growth inhibitory effects on fungi | 250 µg/mL | Compounds isolated from seeds | 2.81–56.2% (inhibition) | [13] | ||
Inhibitory activities on the growth of different fungi were determined by microspectrophotometry | 15 μg/ml | SPE10 (a dimeric plant defensin protein) from the seeds of P. erosus | IC50 of 15 μg/mL (most effective against Bipolaris maydis) |
[95] | ||
Inhibitory activities on the growth of fungi (Trichoderma viride and Chrysosporium luteum) | 6.2–12.5 μg | PaAFP (the protein isolated and purified from the P. erosus seeds | Trichoderma viride and Chrysosporium luteum at 6.2 μg and 12.5 μg per disc, respectively, inhibited growth | [94] | ||
6 | Anticancer | Human hepatoma cell line HuH-7 |
0.06 mL/well | Pachyerosin protein isolated from seeds of P. erosus | IC50 of 0.050 ± 0.004 nM for pachyerosin(immunotoxin) and IC50 of 117.92 ± 10.21 nM for pachyerosin | [11] |
The viability of K562 cells determined by the MTT assay | 0.06 mL/well | P. erosus seed extract (acetone) and compound rotenone from seed extract | The P. erosus extract and rotenone displayed IC50 40.5 mg/mL and 13.05 mM, respectively |
[38] |